Corporate Europe Observatory

Exposing the power of corporate lobbying in the EU

ANS panel industry links in La Libre Belgique

  • Dansk
  • Nederlands
  • English
  • Suomi
  • Français
  • Deutsch
  • Ελληνικά
  • Italiano
  • Bokmål
  • Polski
  • Portuguese
  • Română
  • Slovenščina
  • Español
  • Svenska

Deux experts aux intérêts cachés, La Libre Belgique, Tuesday 13 September 2011

New research by Corporate Europe Observatory (CEO) and Réseau Environnement Santé (RES) which found that two of the new experts appointed by EFSA to the panel responsible for looking at food additives have failed to declare consulting activities for the food industry-funded think tank and lobby group International Life Sciences Institute (ILSI) was covered in La Libre Belgique.

See link and pdf of the article below.

 

Our correspondence with Pr. Anne Glover, the current Chief Scientific Adviser to the President of the European Commission (CSA), on her role in the European Commission's review of endocrine disrupting chemicals shows how the very existence of her position was used by business-friendly interests to convey key messages to the top of the European Commission's hierarchy, playing a determining role in the massive delay now inflicted to the European Commission's handling of this important public health regulation. We ask that the CSA position is not renewed in the new Juncker Commission.
Will EFSA become more transparent, and to lobbyists or scientists? After its public consultation on its draft transparency policy, the Authority must now choose.
Corporate Europe Observatory (CEO) today criticised the plenary vote of MEPs to approve the Jean-Claude Juncker Commission.
CEO just responded to the European Ombudsman’s public consultation on transparency in the negotiations over the Transatlantic Trade and Investment Partnership (TTIP), outlining suggestions for ending the secrecy in the EU-US trade talks.

Corporate Europe Forum